Study by USP and Fiocruz shows that cannabidiol may reverse symptoms associated with autism in an animal model, paving the way for new treatments of ASD
Research from USP reveals how cannabis and antipsychotics affect patients with schizophrenia, pointing to new therapeutic pathways
Clinical research suggests improvement in pain perception and emotional symptoms
Project creates a phytochemical database and seeks innovative protocols to ensure safety, quality, and efficacy of cannabinoid products
Experts point out that federal legalization could open doors for national trademarks, but obstacles still persist